- Home
- PRFX vs SDSTW Comparison
PRFX vs SDSTW Comparison
Compare PRFX & SDSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- SDSTW
- Stock Information
- Founded
- PRFX 2007
- SDSTW N/A
- Country
- PRFX Israel
- SDSTW United States
- Employees
- PRFX N/A
- SDSTW 8
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- SDSTW
- Sector
- PRFX Health Care
- SDSTW
- Exchange
- PRFX Nasdaq
- SDSTW Nasdaq
- Market Cap
- PRFX 2.9M
- SDSTW 3.0M
- IPO Year
- PRFX 2020
- SDSTW N/A
- Fundamental
- Price
- PRFX $1.40
- SDSTW $0.06
- Analyst Decision
- PRFX Hold
- SDSTW
- Analyst Count
- PRFX 1
- SDSTW 0
- Target Price
- PRFX N/A
- SDSTW N/A
- AVG Volume (30 Days)
- PRFX 326.0K
- SDSTW 41.6K
- Earning Date
- PRFX 08-14-2025
- SDSTW 03-26-2025
- Dividend Yield
- PRFX N/A
- SDSTW N/A
- EPS Growth
- PRFX N/A
- SDSTW N/A
- EPS
- PRFX N/A
- SDSTW N/A
- Revenue
- PRFX N/A
- SDSTW N/A
- Revenue This Year
- PRFX N/A
- SDSTW N/A
- Revenue Next Year
- PRFX N/A
- SDSTW N/A
- P/E Ratio
- PRFX N/A
- SDSTW N/A
- Revenue Growth
- PRFX N/A
- SDSTW N/A
- 52 Week Low
- PRFX $1.25
- SDSTW $0.10
- 52 Week High
- PRFX $16.63
- SDSTW $0.12
- Technical
- Relative Strength Index (RSI)
- PRFX 35.72
- SDSTW N/A
- Support Level
- PRFX $1.25
- SDSTW N/A
- Resistance Level
- PRFX $1.44
- SDSTW N/A
- Average True Range (ATR)
- PRFX 0.10
- SDSTW 0.00
- MACD
- PRFX 0.01
- SDSTW 0.00
- Stochastic Oscillator
- PRFX 50.00
- SDSTW 0.00
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).